

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ATP synthesis coupled proton transport (GO:0015986) | 9.50819321 |
| 2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 9.50819321 |
| 3 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 8.48026763 |
| 4 | * respiratory electron transport chain (GO:0022904) | 8.00432031 |
| 5 | * electron transport chain (GO:0022900) | 7.82521901 |
| 6 | chaperone-mediated protein transport (GO:0072321) | 5.75639068 |
| 7 | viral transcription (GO:0019083) | 5.53545800 |
| 8 | ATP biosynthetic process (GO:0006754) | 5.35888306 |
| 9 | translational termination (GO:0006415) | 5.25271534 |
| 10 | oxidative phosphorylation (GO:0006119) | 5.11143757 |
| 11 | ribosomal small subunit biogenesis (GO:0042274) | 5.08577714 |
| 12 | * hydrogen ion transmembrane transport (GO:1902600) | 5.07816363 |
| 13 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.96230027 |
| 14 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 4.93426185 |
| 15 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 4.84300397 |
| 16 | cotranslational protein targeting to membrane (GO:0006613) | 4.76919614 |
| 17 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.76880630 |
| 18 | protein complex biogenesis (GO:0070271) | 4.72400757 |
| 19 | protein targeting to ER (GO:0045047) | 4.72149977 |
| 20 | inner mitochondrial membrane organization (GO:0007007) | 4.71826216 |
| 21 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.60702928 |
| 22 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.60702928 |
| 23 | NADH dehydrogenase complex assembly (GO:0010257) | 4.60702928 |
| 24 | protein localization to endoplasmic reticulum (GO:0070972) | 4.51812412 |
| 25 | translational elongation (GO:0006414) | 4.50695382 |
| 26 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.49422139 |
| 27 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 4.41931995 |
| 28 | * proton transport (GO:0015992) | 4.36914487 |
| 29 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.35553189 |
| 30 | * hydrogen transport (GO:0006818) | 4.30148653 |
| 31 | cellular protein complex disassembly (GO:0043624) | 4.24682757 |
| 32 | viral life cycle (GO:0019058) | 4.19324979 |
| 33 | regulation of oxidative phosphorylation (GO:0002082) | 4.12748977 |
| 34 | DNA deamination (GO:0045006) | 4.10327053 |
| 35 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.99789648 |
| 36 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.97951654 |
| 37 | protein targeting to mitochondrion (GO:0006626) | 3.91479645 |
| 38 | ribosomal small subunit assembly (GO:0000028) | 3.89386973 |
| 39 | establishment of protein localization to mitochondrion (GO:0072655) | 3.88212013 |
| 40 | protein neddylation (GO:0045116) | 3.82247426 |
| 41 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.79522224 |
| 42 | protein localization to mitochondrion (GO:0070585) | 3.72373986 |
| 43 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.69507789 |
| 44 | negative regulation of ligase activity (GO:0051352) | 3.69507789 |
| 45 | termination of RNA polymerase III transcription (GO:0006386) | 3.68947773 |
| 46 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.68947773 |
| 47 | mitochondrial transport (GO:0006839) | 3.64678448 |
| 48 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.63092357 |
| 49 | translational initiation (GO:0006413) | 3.62037697 |
| 50 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.58230229 |
| 51 | regulation of mitochondrial translation (GO:0070129) | 3.54782694 |
| 52 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.54092430 |
| 53 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.52464771 |
| 54 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.52464771 |
| 55 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.51495609 |
| 56 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.49740815 |
| 57 | regulation of cellular respiration (GO:0043457) | 3.47275992 |
| 58 | GTP biosynthetic process (GO:0006183) | 3.44808761 |
| 59 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.44637241 |
| 60 | protein complex disassembly (GO:0043241) | 3.42422134 |
| 61 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.39762763 |
| 62 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.39762763 |
| 63 | protein maturation by protein folding (GO:0022417) | 3.38934251 |
| 64 | translation (GO:0006412) | 3.38726799 |
| 65 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.36718913 |
| 66 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.36718913 |
| 67 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.36718913 |
| 68 | mRNA catabolic process (GO:0006402) | 3.32499011 |
| 69 | protein targeting to membrane (GO:0006612) | 3.32492994 |
| 70 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.28877509 |
| 71 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.28877509 |
| 72 | macromolecular complex disassembly (GO:0032984) | 3.28495589 |
| 73 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.24986035 |
| 74 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.24986035 |
| 75 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.23542326 |
| 76 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.21960779 |
| 77 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.21593205 |
| 78 | aerobic respiration (GO:0009060) | 3.17353728 |
| 79 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.15896117 |
| 80 | respiratory chain complex IV assembly (GO:0008535) | 3.14359398 |
| 81 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.13225919 |
| 82 | intracellular protein transmembrane import (GO:0044743) | 3.12900542 |
| 83 | establishment of viral latency (GO:0019043) | 3.12170255 |
| 84 | * generation of precursor metabolites and energy (GO:0006091) | 3.09361753 |
| 85 | positive regulation of ligase activity (GO:0051351) | 3.06816446 |
| 86 | neuronal action potential propagation (GO:0019227) | 3.06570829 |
| 87 | rRNA modification (GO:0000154) | 3.04360395 |
| 88 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.03613323 |
| 89 | RNA catabolic process (GO:0006401) | 3.01720540 |
| 90 | spliceosomal snRNP assembly (GO:0000387) | 2.99121137 |
| 91 | UTP biosynthetic process (GO:0006228) | 2.96538243 |
| 92 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.94841314 |
| 93 | purine ribonucleoside biosynthetic process (GO:0046129) | 2.90281613 |
| 94 | purine nucleoside biosynthetic process (GO:0042451) | 2.90281613 |
| 95 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.89049383 |
| 96 | cytochrome complex assembly (GO:0017004) | 2.88791035 |
| 97 | establishment of integrated proviral latency (GO:0075713) | 2.88743919 |
| 98 | ribosomal large subunit biogenesis (GO:0042273) | 2.88516818 |
| 99 | maturation of SSU-rRNA (GO:0030490) | 2.88057914 |
| 100 | sequestering of actin monomers (GO:0042989) | 2.84333901 |
| 101 | negative regulation of microtubule polymerization (GO:0031115) | 2.83474922 |
| 102 | UTP metabolic process (GO:0046051) | 2.83052572 |
| 103 | NADH metabolic process (GO:0006734) | 2.82522126 |
| 104 | detection of temperature stimulus (GO:0016048) | 2.77226209 |
| 105 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.75479301 |
| 106 | protein targeting (GO:0006605) | 2.73193643 |
| 107 | establishment of protein localization to membrane (GO:0090150) | 2.70962709 |
| 108 | ribonucleoside monophosphate biosynthetic process (GO:0009156) | 2.69898105 |
| 109 | removal of superoxide radicals (GO:0019430) | 2.69594109 |
| 110 | cellular response to superoxide (GO:0071451) | 2.69594109 |
| 111 | cellular response to oxygen radical (GO:0071450) | 2.69594109 |
| 112 | synaptic vesicle exocytosis (GO:0016079) | 2.68290660 |
| 113 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.67294316 |
| 114 | GDP-mannose metabolic process (GO:0019673) | 2.66760829 |
| 115 | tricarboxylic acid cycle (GO:0006099) | 2.60061607 |
| 116 | nucleoside monophosphate biosynthetic process (GO:0009124) | 2.58263271 |
| 117 | proteasome assembly (GO:0043248) | 2.55012088 |
| 118 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.53146679 |
| 119 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.52351274 |
| 120 | CTP metabolic process (GO:0046036) | 2.51905426 |
| 121 | CTP biosynthetic process (GO:0006241) | 2.51905426 |
| 122 | cellular component biogenesis (GO:0044085) | 2.50580453 |
| 123 | ribonucleoside biosynthetic process (GO:0042455) | 2.49970809 |
| 124 | aldehyde catabolic process (GO:0046185) | 2.48678354 |
| 125 | heme biosynthetic process (GO:0006783) | 2.47531446 |
| 126 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.47521492 |
| 127 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.47521492 |
| 128 | regulation of protein kinase A signaling (GO:0010738) | 2.47282977 |
| 129 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 10.0517674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.83573407 |
| 2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.85641887 |
| 3 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.68459172 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.59768244 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.32718673 |
| 6 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.24577529 |
| 7 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.18078213 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.14423378 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.02006817 |
| 10 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.96895898 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.94010611 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.93912434 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.80091921 |
| 14 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.73584103 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.62104115 |
| 16 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.47963070 |
| 17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.45988765 |
| 18 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.40294488 |
| 19 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.23194857 |
| 20 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.20367137 |
| 21 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.14534129 |
| 22 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.11864308 |
| 23 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.05708845 |
| 24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.01888636 |
| 25 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 2.01050706 |
| 26 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.00112610 |
| 27 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.99890868 |
| 28 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.98636144 |
| 29 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.89993609 |
| 30 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.85514786 |
| 31 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.84349354 |
| 32 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.81186131 |
| 33 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.80355679 |
| 34 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.72519256 |
| 35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.66240144 |
| 36 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.65026210 |
| 37 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.64856837 |
| 38 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.59628466 |
| 39 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.58057013 |
| 40 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56612357 |
| 41 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.52241790 |
| 42 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.52122988 |
| 43 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.51068416 |
| 44 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.48244089 |
| 45 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.45565314 |
| 46 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.44723729 |
| 47 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.39660586 |
| 48 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.39573045 |
| 49 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.38567430 |
| 50 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.38266787 |
| 51 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.37651074 |
| 52 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.37380986 |
| 53 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.36957239 |
| 54 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.36115644 |
| 55 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.35043541 |
| 56 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.34206693 |
| 57 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.33301203 |
| 58 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32194855 |
| 59 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.31271646 |
| 60 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.30574500 |
| 61 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29878635 |
| 62 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.29463257 |
| 63 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.28746150 |
| 64 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.28265725 |
| 65 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28205025 |
| 66 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.26950478 |
| 67 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.25660728 |
| 68 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.25213772 |
| 69 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.25121778 |
| 70 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.24943924 |
| 71 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.24111889 |
| 72 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.22727418 |
| 73 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.19552081 |
| 74 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.18983042 |
| 75 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.18909977 |
| 76 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.17620291 |
| 77 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.17484237 |
| 78 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.17274252 |
| 79 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16405207 |
| 80 | * FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.15221208 |
| 81 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.14863442 |
| 82 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.12907251 |
| 83 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.12193916 |
| 84 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.11727518 |
| 85 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.11571930 |
| 86 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.10515558 |
| 87 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.10485783 |
| 88 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.10387002 |
| 89 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.10135892 |
| 90 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.09621409 |
| 91 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.09621409 |
| 92 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.08951239 |
| 93 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08751417 |
| 94 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.08507319 |
| 95 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.08251944 |
| 96 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.07065150 |
| 97 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.06436647 |
| 98 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.05447744 |
| 99 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.05054843 |
| 100 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.03991750 |
| 101 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.03845600 |
| 102 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.03092091 |
| 103 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02941321 |
| 104 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.01878147 |
| 105 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00943687 |
| 106 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.00799510 |
| 107 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.00552303 |
| 108 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00203919 |
| 109 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.99493058 |
| 110 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.99457868 |
| 111 | SA1_27219007_Chip-Seq_Bcells_Human | 0.98306648 |
| 112 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.98200620 |
| 113 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.98033470 |
| 114 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.97878326 |
| 115 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97657349 |
| 116 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.95773864 |
| 117 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.95557967 |
| 118 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95369623 |
| 119 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.94691546 |
| 120 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.93442656 |
| 121 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.93150570 |
| 122 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.92468859 |
| 123 | * P68_20966046_ChIP-Seq_HELA_Human | 0.92316996 |
| 124 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.92278240 |
| 125 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.92273641 |
| 126 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91579026 |
| 127 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.91513407 |
| 128 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.91497489 |
| 129 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.90901051 |
| 130 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.90415416 |
| 131 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.88635608 |
| 132 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.85277141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 3.99187569 |
| 2 | MP0003880_abnormal_central_pattern | 3.81991884 |
| 3 | MP0002736_abnormal_nociception_after | 3.40234330 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.35980276 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.25334514 |
| 6 | MP0000372_irregular_coat_pigmentation | 3.11586430 |
| 7 | MP0010030_abnormal_orbit_morphology | 3.06023444 |
| 8 | MP0006036_abnormal_mitochondrial_physio | 2.83444102 |
| 9 | MP0001529_abnormal_vocalization | 2.73890259 |
| 10 | MP0002733_abnormal_thermal_nociception | 2.61172335 |
| 11 | MP0004270_analgesia | 2.53722928 |
| 12 | MP0002735_abnormal_chemical_nociception | 2.49408878 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 2.49260934 |
| 14 | MP0004145_abnormal_muscle_electrophysio | 2.43493369 |
| 15 | MP0001970_abnormal_pain_threshold | 2.40356344 |
| 16 | MP0003635_abnormal_synaptic_transmissio | 2.31456400 |
| 17 | MP0000749_muscle_degeneration | 2.28099492 |
| 18 | MP0004043_abnormal_pH_regulation | 2.25825612 |
| 19 | MP0006276_abnormal_autonomic_nervous | 2.25014196 |
| 20 | MP0009745_abnormal_behavioral_response | 2.24771028 |
| 21 | MP0002064_seizures | 2.18867861 |
| 22 | MP0010386_abnormal_urinary_bladder | 2.13621533 |
| 23 | MP0003186_abnormal_redox_activity | 2.07002445 |
| 24 | MP0002734_abnormal_mechanical_nocicepti | 2.06382640 |
| 25 | MP0000750_abnormal_muscle_regeneration | 2.05068325 |
| 26 | MP0002938_white_spotting | 1.96736927 |
| 27 | MP0003123_paternal_imprinting | 1.95005587 |
| 28 | MP0001905_abnormal_dopamine_level | 1.94762291 |
| 29 | MP0002272_abnormal_nervous_system | 1.94192999 |
| 30 | MP0003329_amyloid_beta_deposits | 1.91812651 |
| 31 | MP0002653_abnormal_ependyma_morphology | 1.89887781 |
| 32 | MP0001440_abnormal_grooming_behavior | 1.88299835 |
| 33 | MP0002822_catalepsy | 1.86615417 |
| 34 | MP0004957_abnormal_blastocyst_morpholog | 1.85767514 |
| 35 | MP0006035_abnormal_mitochondrial_morpho | 1.84369868 |
| 36 | MP0005360_urolithiasis | 1.83042890 |
| 37 | MP0005636_abnormal_mineral_homeostasis | 1.79944804 |
| 38 | MP0002572_abnormal_emotion/affect_behav | 1.76628537 |
| 39 | MP0003693_abnormal_embryo_hatching | 1.73333014 |
| 40 | MP0005451_abnormal_body_composition | 1.73135617 |
| 41 | MP0004142_abnormal_muscle_tone | 1.70281133 |
| 42 | MP0005408_hypopigmentation | 1.67273782 |
| 43 | MP0002063_abnormal_learning/memory/cond | 1.66605827 |
| 44 | MP0009046_muscle_twitch | 1.63379469 |
| 45 | MP0003879_abnormal_hair_cell | 1.61618103 |
| 46 | MP0005332_abnormal_amino_acid | 1.61145804 |
| 47 | MP0008932_abnormal_embryonic_tissue | 1.57438119 |
| 48 | MP0006292_abnormal_olfactory_placode | 1.56610147 |
| 49 | MP0005535_abnormal_body_temperature | 1.55963303 |
| 50 | MP0005084_abnormal_gallbladder_morpholo | 1.55661082 |
| 51 | MP0003315_abnormal_perineum_morphology | 1.54218995 |
| 52 | MP0002638_abnormal_pupillary_reflex | 1.51035218 |
| 53 | MP0001501_abnormal_sleep_pattern | 1.49645980 |
| 54 | MP0002277_abnormal_respiratory_mucosa | 1.46846581 |
| 55 | MP0002163_abnormal_gland_morphology | 1.44776179 |
| 56 | MP0008872_abnormal_physiological_respon | 1.42860680 |
| 57 | MP0001984_abnormal_olfaction | 1.40458279 |
| 58 | MP0002067_abnormal_sensory_capabilities | 1.37579626 |
| 59 | MP0008058_abnormal_DNA_repair | 1.36759638 |
| 60 | MP0005645_abnormal_hypothalamus_physiol | 1.36148142 |
| 61 | MP0003718_maternal_effect | 1.35023805 |
| 62 | MP0009840_abnormal_foam_cell | 1.34716275 |
| 63 | MP0001486_abnormal_startle_reflex | 1.34347142 |
| 64 | MP0004858_abnormal_nervous_system | 1.34044238 |
| 65 | MP0003806_abnormal_nucleotide_metabolis | 1.33582228 |
| 66 | MP0003786_premature_aging | 1.33177510 |
| 67 | MP0005083_abnormal_biliary_tract | 1.32390354 |
| 68 | MP0001346_abnormal_lacrimal_gland | 1.28285338 |
| 69 | MP0002909_abnormal_adrenal_gland | 1.25875747 |
| 70 | MP0003195_calcinosis | 1.25235626 |
| 71 | MP0001765_abnormal_ion_homeostasis | 1.22721068 |
| 72 | MP0005058_abnormal_lysosome_morphology | 1.22363378 |
| 73 | MP0002184_abnormal_innervation | 1.22355448 |
| 74 | MP0004147_increased_porphyrin_level | 1.21829907 |
| 75 | MP0005386_behavior/neurological_phenoty | 1.21322578 |
| 76 | MP0004924_abnormal_behavior | 1.21322578 |
| 77 | MP0005171_absent_coat_pigmentation | 1.20901901 |
| 78 | MP0005670_abnormal_white_adipose | 1.18285064 |
| 79 | MP0008789_abnormal_olfactory_epithelium | 1.17938709 |
| 80 | MP0005423_abnormal_somatic_nervous | 1.17044303 |
| 81 | MP0003077_abnormal_cell_cycle | 1.15921672 |
| 82 | MP0001756_abnormal_urination | 1.15388809 |
| 83 | MP0000747_muscle_weakness | 1.14518178 |
| 84 | MP0006072_abnormal_retinal_apoptosis | 1.11403813 |
| 85 | MP0001485_abnormal_pinna_reflex | 1.09820923 |
| 86 | MP0009643_abnormal_urine_homeostasis | 1.09387932 |
| 87 | MP0001502_abnormal_circadian_rhythm | 1.08260763 |
| 88 | MP0005379_endocrine/exocrine_gland_phen | 1.07429610 |
| 89 | MP0004215_abnormal_myocardial_fiber | 1.06041487 |
| 90 | MP0002234_abnormal_pharynx_morphology | 1.05803262 |
| 91 | MP0003646_muscle_fatigue | 1.05732762 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.04570402 |
| 93 | MP0001664_abnormal_digestion | 1.04253017 |
| 94 | MP0001727_abnormal_embryo_implantation | 1.04003727 |
| 95 | MP0000537_abnormal_urethra_morphology | 1.03646290 |
| 96 | MP0008995_early_reproductive_senescence | 1.03407409 |
| 97 | MP0002095_abnormal_skin_pigmentation | 1.03061148 |
| 98 | MP0000751_myopathy | 1.01824876 |
| 99 | MP0002876_abnormal_thyroid_physiology | 1.01741413 |
| 100 | MP0002066_abnormal_motor_capabilities/c | 1.00848027 |
| 101 | MP0002557_abnormal_social/conspecific_i | 0.99065700 |
| 102 | MP0003111_abnormal_nucleus_morphology | 0.98652787 |
| 103 | MP0001986_abnormal_taste_sensitivity | 0.98244927 |
| 104 | MP0000955_abnormal_spinal_cord | 0.96693343 |
| 105 | MP0000343_altered_response_to | 0.96571094 |
| 106 | MP0004019_abnormal_vitamin_homeostasis | 0.93288767 |
| 107 | MP0003137_abnormal_impulse_conducting | 0.92756257 |
| 108 | MP0000013_abnormal_adipose_tissue | 0.92502452 |
| 109 | MP0001663_abnormal_digestive_system | 0.92399839 |
| 110 | MP0002229_neurodegeneration | 0.92006967 |
| 111 | MP0002090_abnormal_vision | 0.89876493 |
| 112 | MP0010094_abnormal_chromosome_stability | 0.89608867 |
| 113 | MP0004811_abnormal_neuron_physiology | 0.88838449 |
| 114 | MP0008875_abnormal_xenobiotic_pharmacok | 0.88822675 |
| 115 | MP0002139_abnormal_hepatobiliary_system | 0.87915200 |
| 116 | MP0005381_digestive/alimentary_phenotyp | 0.87422474 |
| 117 | MP0000026_abnormal_inner_ear | 0.84281778 |
| 118 | MP0000230_abnormal_systemic_arterial | 0.84119264 |
| 119 | MP0005085_abnormal_gallbladder_physiolo | 0.82415598 |
| 120 | MP0001963_abnormal_hearing_physiology | 0.80306091 |
| 121 | MP0002882_abnormal_neuron_morphology | 0.78651757 |
| 122 | MP0005075_abnormal_melanosome_morpholog | 0.78394589 |
| 123 | MP0003638_abnormal_response/metabolism_ | 0.78020669 |
| 124 | MP0002106_abnormal_muscle_physiology | 0.77956554 |
| 125 | MP0003938_abnormal_ear_development | 0.77933038 |
| 126 | MP0000566_synostosis | 0.76796468 |
| 127 | MP0005266_abnormal_metabolism | 0.75601179 |
| 128 | MP0000759_abnormal_skeletal_muscle | 0.74413104 |
| 129 | MP0005394_taste/olfaction_phenotype | 0.73731973 |
| 130 | MP0005499_abnormal_olfactory_system | 0.73731973 |
| 131 | MP0005551_abnormal_eye_electrophysiolog | 0.73513216 |
| 132 | MP0004742_abnormal_vestibular_system | 0.72761172 |
| 133 | MP0000358_abnormal_cell_content/ | 0.72435519 |
| 134 | MP0002210_abnormal_sex_determination | 0.71765737 |
| 135 | MP0000604_amyloidosis | 0.71592928 |
| 136 | MP0002752_abnormal_somatic_nervous | 0.71100073 |
| 137 | MP0008874_decreased_physiological_sensi | 0.70982516 |
| 138 | MP0001293_anophthalmia | 0.70377392 |
| 139 | MP0005165_increased_susceptibility_to | 0.69518541 |
| 140 | MP0004133_heterotaxia | 0.68593874 |
| 141 | MP0000631_abnormal_neuroendocrine_gland | 0.67254816 |
| 142 | MP0003011_delayed_dark_adaptation | 0.67048850 |
| 143 | MP0003136_yellow_coat_color | 0.65986320 |
| 144 | MP0005330_cardiomyopathy | 0.65296036 |
| 145 | MP0003656_abnormal_erythrocyte_physiolo | 0.65268131 |
| 146 | MP0000538_abnormal_urinary_bladder | 0.65247667 |
| 147 | MP0001764_abnormal_homeostasis | 0.65041093 |
| 148 | MP0002332_abnormal_exercise_endurance | 0.65033769 |
| 149 | MP0001881_abnormal_mammary_gland | 0.63588547 |
| 150 | MP0002972_abnormal_cardiac_muscle | 0.62834929 |
| 151 | MP0002269_muscular_atrophy | 0.61060881 |
| 152 | MP0005369_muscle_phenotype | 0.60795583 |
| 153 | MP0005319_abnormal_enzyme/_coenzyme | 0.60676438 |
| 154 | MP0001944_abnormal_pancreas_morphology | 0.60607014 |
| 155 | MP0004510_myositis | 0.60597406 |
| 156 | MP0009697_abnormal_copulation | 0.57635447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 7.14401958 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 6.64702355 |
| 3 | Mitochondrial inheritance (HP:0001427) | 6.22026340 |
| 4 | Acute encephalopathy (HP:0006846) | 6.20167358 |
| 5 | Progressive macrocephaly (HP:0004481) | 5.92597537 |
| 6 | Myokymia (HP:0002411) | 5.76999629 |
| 7 | Increased CSF lactate (HP:0002490) | 5.34030057 |
| 8 | Hepatocellular necrosis (HP:0001404) | 5.29865815 |
| 9 | Hepatic necrosis (HP:0002605) | 4.91672947 |
| 10 | Increased hepatocellular lipid droplets (HP:0006565) | 4.90604745 |
| 11 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.73130928 |
| 12 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.73130928 |
| 13 | Lipid accumulation in hepatocytes (HP:0006561) | 4.58970164 |
| 14 | Increased intramyocellular lipid droplets (HP:0012240) | 4.58665895 |
| 15 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.56573302 |
| 16 | Cerebral edema (HP:0002181) | 4.48407299 |
| 17 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 4.37255043 |
| 18 | Increased muscle lipid content (HP:0009058) | 4.29446236 |
| 19 | Renal Fanconi syndrome (HP:0001994) | 4.20655950 |
| 20 | Abnormal number of erythroid precursors (HP:0012131) | 3.90929613 |
| 21 | Lactic acidosis (HP:0003128) | 3.90431572 |
| 22 | Respiratory failure (HP:0002878) | 3.88796075 |
| 23 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.77229457 |
| 24 | Exercise intolerance (HP:0003546) | 3.73361890 |
| 25 | 3-Methylglutaconic aciduria (HP:0003535) | 3.61352571 |
| 26 | Optic disc pallor (HP:0000543) | 3.61131296 |
| 27 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.59473058 |
| 28 | Leukodystrophy (HP:0002415) | 3.38711983 |
| 29 | Exertional dyspnea (HP:0002875) | 3.36427075 |
| 30 | Hyperphosphaturia (HP:0003109) | 3.35025825 |
| 31 | Increased serum lactate (HP:0002151) | 3.32484400 |
| 32 | Abnormality of renal resorption (HP:0011038) | 3.05130117 |
| 33 | Macrocytic anemia (HP:0001972) | 2.97972285 |
| 34 | Pheochromocytoma (HP:0002666) | 2.96447945 |
| 35 | Neuroendocrine neoplasm (HP:0100634) | 2.93681331 |
| 36 | Glycosuria (HP:0003076) | 2.90691018 |
| 37 | Abnormality of urine glucose concentration (HP:0011016) | 2.90691018 |
| 38 | Respiratory difficulties (HP:0002880) | 2.86254029 |
| 39 | Abnormality of glycolysis (HP:0004366) | 2.76582838 |
| 40 | Increased serum pyruvate (HP:0003542) | 2.76582838 |
| 41 | Abnormal urine phosphate concentration (HP:0012599) | 2.76527676 |
| 42 | Lethargy (HP:0001254) | 2.73037110 |
| 43 | Emotional lability (HP:0000712) | 2.61222897 |
| 44 | Type I transferrin isoform profile (HP:0003642) | 2.53290461 |
| 45 | CNS demyelination (HP:0007305) | 2.49175865 |
| 46 | X-linked dominant inheritance (HP:0001423) | 2.47541679 |
| 47 | Reticulocytopenia (HP:0001896) | 2.44564821 |
| 48 | Myotonia (HP:0002486) | 2.43418179 |
| 49 | Sensory axonal neuropathy (HP:0003390) | 2.39604116 |
| 50 | Abnormality of magnesium homeostasis (HP:0004921) | 2.37617481 |
| 51 | Pallor (HP:0000980) | 2.35859168 |
| 52 | Microvesicular hepatic steatosis (HP:0001414) | 2.34247561 |
| 53 | Visual hallucinations (HP:0002367) | 2.29259479 |
| 54 | Myopathic facies (HP:0002058) | 2.28303300 |
| 55 | Vomiting (HP:0002013) | 2.28290464 |
| 56 | Rhabdomyolysis (HP:0003201) | 2.28010208 |
| 57 | Focal motor seizures (HP:0011153) | 2.26409613 |
| 58 | Myoglobinuria (HP:0002913) | 2.22408026 |
| 59 | Aplastic anemia (HP:0001915) | 2.16618554 |
| 60 | Muscle fiber inclusion bodies (HP:0100299) | 2.15778307 |
| 61 | Delusions (HP:0000746) | 2.15087593 |
| 62 | Degeneration of anterior horn cells (HP:0002398) | 2.14257132 |
| 63 | Abnormality of the anterior horn cell (HP:0006802) | 2.14257132 |
| 64 | Hyperactive renin-angiotensin system (HP:0000841) | 2.09227818 |
| 65 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.08742982 |
| 66 | Anxiety (HP:0000739) | 2.07410571 |
| 67 | Metabolic alkalosis (HP:0200114) | 2.07402528 |
| 68 | Nemaline bodies (HP:0003798) | 2.07074686 |
| 69 | Renal tubular dysfunction (HP:0000124) | 2.03409858 |
| 70 | Generalized aminoaciduria (HP:0002909) | 2.03132142 |
| 71 | Abnormal gallbladder physiology (HP:0012438) | 2.02893621 |
| 72 | Cholecystitis (HP:0001082) | 2.02893621 |
| 73 | Ragged-red muscle fibers (HP:0003200) | 2.01860098 |
| 74 | Testicular atrophy (HP:0000029) | 1.99210488 |
| 75 | Dicarboxylic aciduria (HP:0003215) | 1.99150640 |
| 76 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.99150640 |
| 77 | Abnormal hemoglobin (HP:0011902) | 1.95477898 |
| 78 | Increased circulating renin level (HP:0000848) | 1.94751480 |
| 79 | Ketoacidosis (HP:0001993) | 1.94665882 |
| 80 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.94612350 |
| 81 | Hypokalemic alkalosis (HP:0001949) | 1.94077147 |
| 82 | Hypomagnesemia (HP:0002917) | 1.93908280 |
| 83 | Exercise-induced muscle cramps (HP:0003710) | 1.93269779 |
| 84 | Abnormality of reticulocytes (HP:0004312) | 1.90718194 |
| 85 | Congenital, generalized hypertrichosis (HP:0004540) | 1.88141157 |
| 86 | Reduced antithrombin III activity (HP:0001976) | 1.88095758 |
| 87 | Abnormal protein glycosylation (HP:0012346) | 1.87515636 |
| 88 | Abnormal glycosylation (HP:0012345) | 1.87515636 |
| 89 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.87515636 |
| 90 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.87515636 |
| 91 | Nausea (HP:0002018) | 1.86776333 |
| 92 | Abnormality of placental membranes (HP:0011409) | 1.86528098 |
| 93 | Amniotic constriction ring (HP:0009775) | 1.86528098 |
| 94 | Conjunctival hamartoma (HP:0100780) | 1.86284046 |
| 95 | Oral leukoplakia (HP:0002745) | 1.82548079 |
| 96 | Pancytopenia (HP:0001876) | 1.81733263 |
| 97 | Rough bone trabeculation (HP:0100670) | 1.79703869 |
| 98 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.75720249 |
| 99 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.73773768 |
| 100 | Retinal dysplasia (HP:0007973) | 1.73557513 |
| 101 | Cerebral hemorrhage (HP:0001342) | 1.72940722 |
| 102 | Muscle stiffness (HP:0003552) | 1.72699025 |
| 103 | Absence seizures (HP:0002121) | 1.68890927 |
| 104 | Athetosis (HP:0002305) | 1.68750528 |
| 105 | Hypokinesia (HP:0002375) | 1.68219928 |
| 106 | Hyperglycinuria (HP:0003108) | 1.68211358 |
| 107 | Gliosis (HP:0002171) | 1.68090928 |
| 108 | Microretrognathia (HP:0000308) | 1.67610528 |
| 109 | Methylmalonic aciduria (HP:0012120) | 1.67523567 |
| 110 | Palpitations (HP:0001962) | 1.67482942 |
| 111 | Poor suck (HP:0002033) | 1.66045646 |
| 112 | Calf muscle hypertrophy (HP:0008981) | 1.65465388 |
| 113 | Opisthotonus (HP:0002179) | 1.64980904 |
| 114 | Hyperaldosteronism (HP:0000859) | 1.64691210 |
| 115 | Sparse eyelashes (HP:0000653) | 1.64592010 |
| 116 | Concave nail (HP:0001598) | 1.64204058 |
| 117 | Gout (HP:0001997) | 1.64099329 |
| 118 | Partial duplication of thumb phalanx (HP:0009944) | 1.63992481 |
| 119 | Renal salt wasting (HP:0000127) | 1.63173155 |
| 120 | Alkalosis (HP:0001948) | 1.62433143 |
| 121 | Atonic seizures (HP:0010819) | 1.61076472 |
| 122 | Prolonged neonatal jaundice (HP:0006579) | 1.60945408 |
| 123 | Blindness (HP:0000618) | 1.59057662 |
| 124 | Partial duplication of the phalanx of hand (HP:0009999) | 1.57728597 |
| 125 | Late onset (HP:0003584) | 1.57049060 |
| 126 | Abnormality of secondary sexual hair (HP:0009888) | 1.56709136 |
| 127 | Abnormality of the axillary hair (HP:0100134) | 1.56709136 |
| 128 | Delayed CNS myelination (HP:0002188) | 1.56061390 |
| 129 | Cerebral hypomyelination (HP:0006808) | 1.55239516 |
| 130 | Muscle fiber atrophy (HP:0100295) | 1.55194486 |
| 131 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.55076047 |
| 132 | Distal lower limb muscle weakness (HP:0009053) | 1.54818563 |
| 133 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.54578206 |
| 134 | Sudden death (HP:0001699) | 1.54104996 |
| 135 | Ketosis (HP:0001946) | 1.53300617 |
| 136 | Progressive muscle weakness (HP:0003323) | 1.53237911 |
| 137 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.50142131 |
| 138 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.48840218 |
| 139 | Craniofacial dystonia (HP:0012179) | 1.47920006 |
| 140 | Adrenal overactivity (HP:0002717) | 1.47611847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 6.22495374 |
| 2 | ARAF | 4.78704596 |
| 3 | NME2 | 4.26435055 |
| 4 | MAP3K12 | 3.36571648 |
| 5 | GRK5 | 3.19590620 |
| 6 | NME1 | 2.96547465 |
| 7 | PIM2 | 2.53482727 |
| 8 | STK16 | 2.16946378 |
| 9 | TESK2 | 2.06384065 |
| 10 | EPHA4 | 2.06377257 |
| 11 | WNK4 | 2.00928982 |
| 12 | CDK19 | 1.99720973 |
| 13 | MYLK | 1.98158073 |
| 14 | MAP3K9 | 1.96115757 |
| 15 | KSR2 | 1.92375155 |
| 16 | BRAF | 1.85474762 |
| 17 | ZAK | 1.82724490 |
| 18 | NTRK3 | 1.82251214 |
| 19 | LIMK1 | 1.80936743 |
| 20 | BCKDK | 1.80746596 |
| 21 | OXSR1 | 1.68045638 |
| 22 | OBSCN | 1.65202012 |
| 23 | MAP3K11 | 1.56348402 |
| 24 | IRAK3 | 1.53469907 |
| 25 | MINK1 | 1.53308450 |
| 26 | TESK1 | 1.51196261 |
| 27 | PHKG1 | 1.49084496 |
| 28 | PHKG2 | 1.49084496 |
| 29 | RAF1 | 1.46057221 |
| 30 | DAPK3 | 1.45492364 |
| 31 | RIPK4 | 1.44791737 |
| 32 | DAPK1 | 1.44010501 |
| 33 | MUSK | 1.41442843 |
| 34 | ABL2 | 1.41164030 |
| 35 | MST4 | 1.34404202 |
| 36 | GRK6 | 1.33846724 |
| 37 | STK39 | 1.32025296 |
| 38 | PDK2 | 1.31795471 |
| 39 | VRK1 | 1.30770240 |
| 40 | EPHB2 | 1.29375091 |
| 41 | WNK3 | 1.29168667 |
| 42 | CDC7 | 1.28969331 |
| 43 | LMTK2 | 1.20711706 |
| 44 | DAPK2 | 1.18628472 |
| 45 | CCNB1 | 1.17628204 |
| 46 | UHMK1 | 1.16849928 |
| 47 | NTRK1 | 1.13016019 |
| 48 | SRPK1 | 1.09988801 |
| 49 | ADRBK2 | 1.09877701 |
| 50 | ADRBK1 | 1.09145557 |
| 51 | SCYL2 | 1.07286841 |
| 52 | ILK | 1.06515312 |
| 53 | EPHA2 | 0.98790223 |
| 54 | MAP3K2 | 0.96643615 |
| 55 | AURKB | 0.95692826 |
| 56 | LRRK2 | 0.94675142 |
| 57 | TAF1 | 0.93441301 |
| 58 | CDK8 | 0.93089799 |
| 59 | RPS6KA5 | 0.91526455 |
| 60 | GRK7 | 0.89111872 |
| 61 | TLK1 | 0.88944697 |
| 62 | BUB1 | 0.88711884 |
| 63 | CDK14 | 0.87083793 |
| 64 | SMG1 | 0.85950762 |
| 65 | CAMK2B | 0.83555335 |
| 66 | WEE1 | 0.83348132 |
| 67 | NEK1 | 0.83315104 |
| 68 | TAOK2 | 0.82071190 |
| 69 | PAK6 | 0.80770736 |
| 70 | KDR | 0.78433027 |
| 71 | CAMK2G | 0.75632303 |
| 72 | CDK5 | 0.75483050 |
| 73 | CDK11A | 0.74496574 |
| 74 | PRKCG | 0.73891418 |
| 75 | CDK15 | 0.72186839 |
| 76 | PAK1 | 0.71769891 |
| 77 | BRSK1 | 0.71321229 |
| 78 | MAP2K7 | 0.70413546 |
| 79 | AURKA | 0.70191340 |
| 80 | CDK18 | 0.69639765 |
| 81 | DYRK3 | 0.68738398 |
| 82 | TNIK | 0.68650955 |
| 83 | PTK2B | 0.68529534 |
| 84 | CSNK2A2 | 0.67596217 |
| 85 | TAOK1 | 0.66873048 |
| 86 | CAMK2D | 0.66832027 |
| 87 | PLK1 | 0.66511999 |
| 88 | CAMK2A | 0.66483558 |
| 89 | PRKCI | 0.65995980 |
| 90 | PNCK | 0.65735392 |
| 91 | PINK1 | 0.65005428 |
| 92 | EIF2AK1 | 0.64750496 |
| 93 | MAPK13 | 0.64436547 |
| 94 | MAP2K4 | 0.64359498 |
| 95 | MST1R | 0.64327145 |
| 96 | MAP2K1 | 0.63681567 |
| 97 | MAP2K2 | 0.63291397 |
| 98 | TTK | 0.62500412 |
| 99 | MOS | 0.61778699 |
| 100 | MAPKAPK5 | 0.61773531 |
| 101 | MAP4K2 | 0.61459944 |
| 102 | PBK | 0.60544141 |
| 103 | STK4 | 0.60266016 |
| 104 | CHEK2 | 0.59943156 |
| 105 | CSNK2A1 | 0.57855662 |
| 106 | FGR | 0.55835265 |
| 107 | AKT2 | 0.55105893 |
| 108 | CAMKK2 | 0.54710829 |
| 109 | CAMK1 | 0.51883864 |
| 110 | TRIB3 | 0.50706225 |
| 111 | PRKACA | 0.50667753 |
| 112 | PLK3 | 0.50083199 |
| 113 | MAPKAPK3 | 0.50074912 |
| 114 | BMPR2 | 0.49835144 |
| 115 | PLK2 | 0.49720464 |
| 116 | EIF2AK3 | 0.48360681 |
| 117 | CSNK1G2 | 0.47509780 |
| 118 | MAP3K1 | 0.47292557 |
| 119 | ROCK2 | 0.45527281 |
| 120 | CSNK1G1 | 0.45498567 |
| 121 | LATS2 | 0.45081173 |
| 122 | MAP3K8 | 0.44759332 |
| 123 | MAP3K4 | 0.43897039 |
| 124 | CSNK1G3 | 0.41106945 |
| 125 | PAK4 | 0.40698270 |
| 126 | CDK7 | 0.39217686 |
| 127 | CSNK1A1L | 0.38681906 |
| 128 | TNK2 | 0.38101161 |
| 129 | IRAK2 | 0.37784570 |
| 130 | PRKG2 | 0.35098774 |
| 131 | MAPK15 | 0.33988707 |
| 132 | MAPK4 | 0.33684466 |
| 133 | CASK | 0.33576279 |
| 134 | TTN | 0.33522932 |
| 135 | MARK1 | 0.33382140 |
| 136 | DYRK2 | 0.33208629 |
| 137 | SIK1 | 0.32713747 |
| 138 | PRKCA | 0.32659752 |
| 139 | MARK3 | 0.29446436 |
| 140 | RPS6KB2 | 0.28972364 |
| 141 | INSRR | 0.27235704 |
| 142 | CSNK1A1 | 0.25347059 |
| 143 | ATR | 0.23248412 |
| 144 | DYRK1B | 0.21503511 |
| 145 | PASK | 0.21477529 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 6.69936155 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 5.78565151 |
| 3 | Alzheimers disease_Homo sapiens_hsa05010 | 4.43468892 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 4.41698528 |
| 5 | Huntingtons disease_Homo sapiens_hsa05016 | 4.00877563 |
| 6 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 3.66440561 |
| 7 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.06982085 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.47605305 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.19056714 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.03281174 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 1.77930362 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.72543182 |
| 13 | Protein export_Homo sapiens_hsa03060 | 1.71882626 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 1.54341435 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45666140 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.43988662 |
| 17 | Sulfur relay system_Homo sapiens_hsa04122 | 1.40902936 |
| 18 | RNA polymerase_Homo sapiens_hsa03020 | 1.38216456 |
| 19 | Homologous recombination_Homo sapiens_hsa03440 | 1.36435506 |
| 20 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.29668523 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.21462066 |
| 22 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.17949924 |
| 23 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.16810436 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.14772847 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.10341498 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.09958402 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.03351585 |
| 28 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.03230328 |
| 29 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.02849523 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.00087137 |
| 31 | Nicotine addiction_Homo sapiens_hsa05033 | 0.99584306 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.96417917 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.96164243 |
| 34 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.95328857 |
| 35 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.94778353 |
| 36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88989937 |
| 37 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.88138331 |
| 38 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.86115250 |
| 39 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.85953129 |
| 40 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84717604 |
| 41 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.83192784 |
| 42 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.80672803 |
| 43 | GABAergic synapse_Homo sapiens_hsa04727 | 0.80188684 |
| 44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77652870 |
| 45 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.77356424 |
| 46 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73683561 |
| 47 | Long-term potentiation_Homo sapiens_hsa04720 | 0.66084166 |
| 48 | Taste transduction_Homo sapiens_hsa04742 | 0.65550559 |
| 49 | Circadian entrainment_Homo sapiens_hsa04713 | 0.65272474 |
| 50 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.63828533 |
| 51 | Peroxisome_Homo sapiens_hsa04146 | 0.63704849 |
| 52 | Salivary secretion_Homo sapiens_hsa04970 | 0.63653553 |
| 53 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.63372829 |
| 54 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62175119 |
| 55 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.61538463 |
| 56 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.60001214 |
| 57 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.59851342 |
| 58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58380548 |
| 59 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.58081345 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.57730464 |
| 61 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.56229190 |
| 62 | RNA transport_Homo sapiens_hsa03013 | 0.56137417 |
| 63 | Olfactory transduction_Homo sapiens_hsa04740 | 0.54812524 |
| 64 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.54499751 |
| 65 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.53468843 |
| 66 | Morphine addiction_Homo sapiens_hsa05032 | 0.52933172 |
| 67 | RNA degradation_Homo sapiens_hsa03018 | 0.52438978 |
| 68 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.51802444 |
| 69 | Purine metabolism_Homo sapiens_hsa00230 | 0.51315125 |
| 70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.51045987 |
| 71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.50897444 |
| 72 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.49082797 |
| 73 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.48886087 |
| 74 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48536356 |
| 75 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48187867 |
| 76 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.47845347 |
| 77 | Insulin secretion_Homo sapiens_hsa04911 | 0.46808894 |
| 78 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.46224284 |
| 79 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.46027554 |
| 80 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.45974786 |
| 81 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.44820766 |
| 82 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.44552654 |
| 83 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.42592054 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42492618 |
| 85 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.39734109 |
| 86 | Basal transcription factors_Homo sapiens_hsa03022 | 0.39669658 |
| 87 | Phototransduction_Homo sapiens_hsa04744 | 0.39462013 |
| 88 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.37302383 |
| 89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.36423791 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36354271 |
| 91 | Mineral absorption_Homo sapiens_hsa04978 | 0.36275070 |
| 92 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.35794806 |
| 93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.31966473 |
| 94 | DNA replication_Homo sapiens_hsa03030 | 0.31462275 |
| 95 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.30426388 |
| 96 | Histidine metabolism_Homo sapiens_hsa00340 | 0.29811404 |
| 97 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.29668831 |
| 98 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.29311564 |
| 99 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.29179939 |
| 100 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.27390708 |
| 101 | Renin secretion_Homo sapiens_hsa04924 | 0.26982098 |
| 102 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.26929234 |
| 103 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.26745634 |
| 104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.26595129 |
| 105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.25504913 |
| 106 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.24817489 |
| 107 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.24514794 |
| 108 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.23315892 |
| 109 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.23022433 |
| 110 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.22824543 |
| 111 | Alcoholism_Homo sapiens_hsa05034 | 0.21396617 |
| 112 | Long-term depression_Homo sapiens_hsa04730 | 0.20733045 |
| 113 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.20089699 |
| 114 | Bile secretion_Homo sapiens_hsa04976 | 0.19975403 |
| 115 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.19873658 |
| 116 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.19218433 |
| 117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.19137149 |
| 118 | Cell cycle_Homo sapiens_hsa04110 | 0.18877922 |
| 119 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.18694103 |
| 120 | Gap junction_Homo sapiens_hsa04540 | 0.17219556 |
| 121 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.16941814 |
| 122 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.16732947 |
| 123 | Spliceosome_Homo sapiens_hsa03040 | 0.15440429 |
| 124 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.12122340 |
| 125 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.10935616 |
| 126 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.10371924 |
| 127 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.04323556 |
| 128 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.03528388 |
| 129 | Other glycan degradation_Homo sapiens_hsa00511 | 0.03474873 |
| 130 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.03193382 |
| 131 | Lysosome_Homo sapiens_hsa04142 | 0.01928328 |
| 132 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.01306813 |

